Evolent Health (EVH) CFO Files Form 3 Showing No Current Share Ownership

Rhea-AI Filing Summary

Evolent Health, Inc. filed an initial insider ownership report for its Chief Financial Officer. The filing shows that, as of the event date of January 2, 2026, the CFO reported beneficial ownership of 0 shares of Class A common stock, held directly. The report also indicates no derivative securities, such as options or warrants, reported as beneficially owned. The form is filed as a single-reporting-person filing and references a Power of Attorney dated December 12, 2025 authorizing execution of the document.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Ramos Mario

Role Chief Financial Officer

Type	Security	Shares	Price	Value
holding	Class A Common Stock	--	--	--

Holdings After Transaction: Class A Common Stock — 0 shares (Direct)

Footnotes (1)

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Accepted by SEC EDGAR 01/05/2026 - 04:10 PM Learn about SEC filing dates

FAQ

What does Evolent Health (EVH) disclose in this insider ownership filing?

The filing discloses the Chief Financial Officer’s initial statement of beneficial ownership, reporting 0 shares of Class A common stock and no derivative securities as of January 2, 2026.

Who is the reporting person in this Evolent Health EVH Form 3?

The reporting person is an officer of Evolent Health, Inc., serving as Chief Financial Officer, and is filing individually as one reporting person.

How many Evolent Health (EVH) Class A shares does the CFO report owning?

The CFO reports beneficial ownership of 0 shares of Class A common stock, held directly, in Table I of the filing.

Are any options or other derivative securities reported for the Evolent Health CFO?

No. Table II for derivative securities is present but does not list any options, warrants, or other derivative securities beneficially owned.

What is the event date for this Evolent Health (EVH) insider ownership statement?

The date of the event requiring the statement is listed as 01/02/2026.

Who signed the Evolent Health (EVH) insider ownership form?

The form is signed by /s/ Jonathan Weinberg, Attorney-in-fact on 01/05/2026, pursuant to a Power of Attorney dated December 12, 2025.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Ramos Mario

(Last) (First) (Middle)

C/O EVOLENT HEALTH, INC.

1812 N. MOORE ST., STE. 1705

(Street)

ARLINGTON VA 22209

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/02/2026

3. Issuer Name and Ticker or Trading Symbol
Evolent Health, Inc. [ EVH ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Common Stock	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

See Exhibit 24.1 - Power of Attorney dated December 12, 2025.

	/s/ Jonathan Weinberg, Attorney-in-fact	01/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.